Recent advances in stem cell therapeutics and tissue engineering strategies

被引：75
作者：
Kwon S.G. [1 ]
Kwon Y.W. [1 ]
Lee T.W. [1 ]
Park G.T. [1 ]
Kim J.H. [1 ,2 ]
机构：
[1] Pusan National University School of Medicine, Department of Physiology, Yangsan, Gyeongsangnam-do
[2] Pusan National University Yangsan Hospital, Research Institute of Convergence Biomedical Science and Technology, Yangsan
来源：
Biomaterials Research | / 22卷 / 1期
关键词：
Biomaterials; Nanoparticle; Stem cells; Tissue engineering; Tissue injury;
D O I：
10.1186/s40824-018-0148-4
中图分类号：
学科分类号：
摘要：
Background: Tissue regeneration includes delivering specific types of cells or cell products to injured tissues or organs for restoration of tissue and organ function. Stem cell therapy has drawn considerable attention since transplantation of stem cells can overcome the limitations of autologous transplantation of patient's tissues; however, it is not perfect for treating diseases. To overcome the hurdles associated with stem cell therapy, tissue engineering techniques have been developed. Development of stem cell technology in combination with tissue engineering has opened new ways of producing engineered tissue substitutes. Several studies have shown that this combination of tissue engineering and stem cell technologies enhances cell viability, differentiation, and therapeutic efficacy of transplanted stem cells. Main body: Stem cells that can be used for tissue regeneration include mesenchymal stem cells, embryonic stem cells, and induced pluripotent stem cells. Transplantation of stem cells alone into injured tissues exhibited low therapeutic efficacy due to poor viability and diminished regenerative activity of transplanted cells. In this review, we will discuss the progress of biomedical engineering, including scaffolds, biomaterials, and tissue engineering techniques to overcome the low therapeutic efficacy of stem cells and to treat human diseases. Conclusion: The combination of stem cell and tissue engineering techniques overcomes the limitations of stem cells in therapy of human diseases, and presents a new path toward regeneration of injured tissues. © 2018 The Author(s).
引用
收藏
相关论文
共 74 条
[1]  
O'Brien F.J., Biomaterials & scaffolds for tissue engineering, Mater Today, 14, 3, pp. 88-95, (2011)
[2]  
Tong Z., Solanki A., Hamilos A., Levy O., Wen K., Yin X., Et al., Application of biomaterials to advance induced pluripotent stem cell research and therapy, EMBO J, 34, 8, pp. 987-1008, (2015)
[3]  
Madl C.M., Heilshorn S.C., Blau H.M., Bioengineering strategies to accelerate stem cell therapeutics, Nature, 557, 7705, pp. 335-342, (2018)
[4]  
Lee E.J., Kasper F.K., Mikos A.G., Biomaterials for tissue engineering, Ann Biomed Eng, 42, 2, pp. 323-337, (2014)
[5]  
Murphy M.B., Moncivais K., Caplan A.I., Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine, Exp Mol Med, 45, (2013)
[6]  
Dimarino A.M., Caplan A.I., Bonfield T.L., Mesenchymal stem cells in tissue repair, Front Immunol, 4, (2013)
[7]  
Fu Y., Karbaat L., Wu L., Leijten J., Both S.K., Karperien M., Trophic effects of mesenchymal stem cells in tissue regeneration, Tissue Eng B Rev, 23, 6, pp. 515-528, (2017)
[8]  
Squillaro T., Peluso G., Galderisi U., Clinical trials with mesenchymal stem cells: an update, Cell Transplant, 25, 5, pp. 829-848, (2016)
[9]  
Jossen V., Bos C., Eibl R., Eibl D., Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challenges, Appl Microbiol Biotechnol, 102, 9, pp. 3981-3994, (2018)
[10]  
Vazin T., Freed W.J., Human embryonic stem cells: derivation, culture, and differentiation: a review, Restor Neurol Neurosci, 28, 4, pp. 589-603, (2010)
12345678